SVB Leerink Begins Coverage on Neurogene (NASDAQ:NGNE)
SVB Leerink initiated coverage on shares of Neurogene (NASDAQ:NGNE – Free Report) in a research report report published on Monday, MarketBeat reports. The firm issued an outperform rating and a $46.00 target price on the stock. Several other equities analysts have also commented on the stock. Stifel Nicolaus initiated coverage on shares of Neurogene in […]
More Stories
AEX Gold (CVE:AEX) Shares Down 1.6% – Time to Sell?
AEX Gold Inc. (CVE:AEX – Get Free Report) shares fell 1.6% on Friday . The stock traded as low as...
AEX Gold (CVE:AEX) Shares Down 1.6% – Time to Sell?
AEX Gold Inc. (CVE:AEX – Get Free Report) shares fell 1.6% on Friday . The stock traded as low as...
Norwegian Air Shuttle ASA (OTCMKTS:NWARF) Shares Down 2.1% – Here’s What Happened
Shares of Norwegian Air Shuttle ASA (OTCMKTS:NWARF – Get Free Report) fell 2.1% during mid-day trading on Friday . The...
Norwegian Air Shuttle ASA (OTCMKTS:NWARF) Shares Down 2.1% – Here’s What Happened
Shares of Norwegian Air Shuttle ASA (OTCMKTS:NWARF – Get Free Report) fell 2.1% during mid-day trading on Friday . The...
iShares JPX-Nikkei 400 ETF (NYSEARCA:JPXN) Stock Price Down 2.4% – Should You Sell?
iShares JPX-Nikkei 400 ETF (NYSEARCA:JPXN – Get Free Report)’s stock price fell 2.4% during trading on Friday . The stock...
iShares JPX-Nikkei 400 ETF (NYSEARCA:JPXN) Stock Price Down 2.4% – Should You Sell?
iShares JPX-Nikkei 400 ETF (NYSEARCA:JPXN – Get Free Report)’s stock price fell 2.4% during trading on Friday . The stock...